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ABSTRACT
Background: Binge eating disorder (BED) is the most common eating disorder in the United
States, it is more prevalent than Anorexia Nervosa and Bulimia combined. BED is characterized
by recurrent episodes of binge eating accompanied by feeling a lack of control and marked
distress over one’s eating behaviors. BED is a serious condition that impairs health-related
quality of life (HRQL) and increases health care costs.
Purpose: The purpose of this project was to identify patients at risk for binge eating disorder at
an outpatient weight loss clinic using the validated BEDS-7 screening tool.
Evidence-based Intervention: The 7-item Binge-Eating Disorder Screener (BEDS-7), a brief
screener for BED, can assist providers in identifying patients who may have BED providing
evidence-based treatment options and/or referrals for additional assessment and potential
diagnosis of BED.
Evaluation/Results: Screening for binge eating was conducted on all new patients seeking
weight loss at the clinic over a 3-month period. Patients who screened positive for binge eating
according to the BEDS-7 screening tool were provided with evidence-based treatment options
including both pharmacological treatment and referral for psychotherapy and counseling.
Implications for Practice: Screening for Binge eating promotes recognition of binge eating
habits in patients undergoing weight loss treatment and awareness about binge eating and its
influence on overall quality of life.
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Background
Binge Eating Disorder (BED) is the most common eating disorder in the United States
compared to Anorexia and Bulimia. Binge eating disorder is characterized by recurrent episodes
of binge eating involving consumption of an amount of food that is significantly larger than most
people would consume in a similar amount of time or under similar circumstances. Binge eating
disorder also features a sense of lack of control over eating during the binge episodes, significant
psychological distress such as shame or guilt about binge eating. A sense of loss of control
during binge episodes is the core feature of BED. Binge eating is not associated with frequent
inappropriate compensatory behavior, such as purging and excessive exercise. (National Eating
Disorders Association, 2016)
An estimated 2.8 million people have BED. Binge eating disorder affects approximately
3.5 percent of women, 2 percent of men. Thirty percent of people seeking weight loss treatment
exhibit symptoms of BED (American Psychological Association [APA], 2012) Binge eating
disorder is most common among women and is seen in all age groups, races and income levels. It
typically emerges in early adulthood but may surface in adolescence and persist well beyond
midlife (Binge Eating Disorder Association, 2016.) In May 2013, the American Psychiatric
Association (APA) recognized BED as a distinct eating disorder in Diagnostic and Statistical
Manual of Mental Disorders, 5th Edition (DSM-5) eliminating the designation of BED as a
provisional diagnosis.
Binge eating disorder has been associated with psychiatric comorbidity as well as health
and psychosocial impairment. Binge eating disorder has been shown to increase the risk of
diabetes, obesity, hypertension, hyperlipidemia, heart disease, osteoarthritis and sleep apnea.
Patients with BED can also suffer from anxiety, depression, low self-esteem or other issues that
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can greatly affect quality of life. Early identification and treatment of binge eating may prevent
progression and reduce the risk of chronic health consequences. Binge eating behavior is often
overlooked and treatment commonly focuses on obesity and its implication as the presenting
problem rather than addressing the core eating psychopathology. It is especially crucial to assess
and screen for BED in primary care. Individuals with binge eating tend to utilize more health
care services than individuals who do not have the disorder. Primary care providers play a
pivotal role in screening, treating and referring patients for specialty treatment (Brownley et al.,
2016).
Treatment of BED aims to reduce binge eating frequency and disordered eating, improve
metabolic health and weight, and regulate mood. Treatment approaches include psychological
and behavioral treatment, pharmacologic treatment, and combinations of the two approaches. Of
the pharmacologic approaches, the anti-epileptic drug Topiramate has been found to be useful in
BED with obesity, decreasing weight and obsessive-compulsive eating pathology as well as
eating impulsivity. According to Brownley et al. (2016), Topiramate was associated with greater
reductions in binge eating and produced greater increases in cognitive restraint and reductions in
hunger, disinhibition and impulsivity (Brownley et al. 2016).
Purpose/Aims
The aim of this evidence-based project is to determine the prevalence of patients at risk
for BED by screening for binge eating in patients undergoing a weight loss program. The goal is
to identify patients at risk and provide them with adequate support and referrals. The purpose of
the project is to increase awareness regarding eating habits and its effects on weight gain or
inability to lose weight. According to Zwaan (2010), the prevalence of BED has been found to be
30 percent in individuals who seek weight control treatment. Evidence recommends that
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treatment for patients who binge eat should be directed at the disordered eating and associated
psychopathology. Undetected and untreated BED can have significant negative implications for
health given that it is associated with continued weight gain. Individuals engaging in highfrequency binge eating may continue to gain weight even when concurrently participating in
weight management treatment (Zwaan, 2010).
Literature Review
A comprehensive literature review was conducted to identify articles published
between 2009 and 2017. Literature has focused solely on Anorexia and Bulimia as the core
eating disorders and with a lack of literature on binge eating and its effects. Search engines used
included CINAHL, PubMed, Science Direct, Ovid online databases and Cochrane database for
systematic reviews. Key terms used for searching engines included binge eating disorder, binge
eating, screening for binge eating and treatment for binge eating. A total of 20 articles were
reviewed, all of which were relevant, with a total of 6 articles used to support the evidence-based
project.
Amianto, Ottone, Abbate, & Fassino (2016), conducted a systematic review and metaanalysis looking at 10 articles focusing on the prevalence of binge eating disorder in patients
with obesity. The prevalence of BED was found to be at 30 percent in individuals seeking weight
control treatment. Binge eating disorder was found to be more equal in gender ratio (65 percent
female, 35 percent male) than in Bulimia Nervosa, for which only about 10 percent of persons
affected are men. Approximately 30 percent of those participating in weight loss programs and
70 percent of individuals in Overeaters Anonymous display BED. The studies also found a
positive correlation between binge eating severity and degree of obesity. Binge eating obese had
an earlier onset of obesity than non-binge eating obese, started dieting at an earlier age, started

SCREENING FOR BINGE EATING DISORDER IN PATIENTS

6

worrying about their weight at an earlier age, reported a higher prevalence of marked weight
fluctuations in the past and spent more time during adulthood trying to lose weight.
Dorflinger, Ruser, & Masheb (2017), conducted a prospective cohort study looking at the
prevalence of binge eating disorder in veterans referred to a primary care-based weight
management program. The sample size consisted of 116 veterans with an average BMI of 37.9.
Eighty-nine percent were male, and eleven percent were female. Frequency of binge eating
ranged from zero to 21 episodes per week. All participants completed the Questionnaire of
Eating and Weight patterns, a validated tool to screen for binge eating. The prevalence of BED
was 7.76 percent. According to this article, BED is associated with medical and psychiatric
conditions commonly seen and managed in primary care. The disorder typically goes undetected
and untreated as there are a lack of assessment tools for use in primary care.
According to Dorflinger et al. (2017), primary care providers often do not recognize the
presence of binge eating in their patients and binge eating is rarely assessed in primary care.
Individuals who binge eat are at a higher risk of medical comorbidities that are commonly seen
and treated in primary care, such as metabolic syndrome and cardiovascular disorders, and report
higher rates of disability and impairment. It is crucial that primary care practitioners screen for
this disorder and provide patients with appropriate treatment and referrals.
Zwaan (2010) conducted a systematic review exploring the evidence on the efficacy of
binge eating treatment modalities. The study concluded that eating disorder treatments such as
cognitive behavioral therapy or interpersonal psychotherapy improve binge eating with
abstinence rates of about 50 percent. Antidepressants were also found to be successful in
reducing binge eating frequency. The study also looked at self-help as a treatment option. Selfhelp is less costly compared to psychotherapy and may help facilitate the dissemination of

SCREENING FOR BINGE EATING DISORDER IN PATIENTS

7

treatment to a wider population of individuals. Self-help can be conducted in various modes
including group format, online, by video, and by telephone making it easily accessible.
Abstinence rates of 40-50 percent could be achieved after 8-12 weeks of working with a selfhelp manual.
A systematic review and meta-analysis conducted by Brownley et al., (2016) analyzed 34
trials and determined that therapists-led cognitive behavioral therapy, lisdexamfetamine, second
generation antidepressants (mainly selective serotonin reuptake inhibitors) and Topiramate were
effective in decreasing binge-eating frequency, increased binge-eating abstinence and improved
other eating-related psychological outcomes. Topiramate and lisdexamfetamine were effective in
reducing weight in adults with binge eating disorder.
Brewerton (2000), conducted a systematic review of the evidence on the diagnosis and
treatment options for BED. The study analyzed 15 articles pertaining to the medical and
psychiatric comorbidity associated with BED. Medical conditions associated with BED included
higher mortality and morbidity from adult-onset (type 2) diabetes mellitus, obesity,
hyperlipidemias, cardiovascular diseases, several cancers and sleep apneas. The disease
prevalence increases as body mass index (BMI) increases. Binge eating occurs in a subset of
obese patients in response to emotional stress, a phenomenon known as ‘emotional eating’.
Patients with binge eating disorder were found to be more likely to over-eat in response to
negative emotional states and were also found to have higher rates of anxiety, major depression,
post-traumatic stress disorder and impulsive disorders such as compulsive buying and
kleptomania. The study concluded that cognitive behavioral therapy and pharmacological
therapy with antidepressants and Topiramate are effective in treating BED.
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Perkins, Murphy, Schmidt, & Williams, (2009) conducted a systematic review of 15
studies and evaluated the effectiveness of pure self-help and guided self-help interventions for
BED. These treatment modalities have some utility as a first step treatment and have potential as
an alternative to formal therapist-delivered psychological therapy. These forms of therapy for
BED allow treatments with proven efficacy to be accessed with minimum delay. They were also
found to be popular and acceptable to many patients and cost associated was low. Patients found
these options attractive as they avoid the stigma or embarrassment of formal psychotherapy.
Patients with BED are often ashamed of their disorder and find it hard to confide in a therapist
about their symptoms. The pure self-help and guided self-help allow patients to work in their
own time and pace. Patients reported a sense of empowerment and thus promoted collaboration.
These treatments are flexible as, they allow patient to renew or update treatments as often as they
wish. They are also important in reinforcing and consolidating information about BED and can
be used to focus on teaching patients about this disorder, health implications, and better eating
habits.
The Agency for Healthcare Research and Quality [AHRQ] (2015) conducted a systematic
review of evidence on the effectiveness of binge eating treatments and to help patients make
informed choices among treatment alternatives. Therapist-led cognitive behavioral therapy was
found to reduce binge eating frequency and increase binge eating abstinence. Eight randomized
controlled trials (RCTs) (all placebo controlled) examined the effectiveness of antidepressants
for treating BED patients. As a class, antidepressants were associated with better binge-eating
outcomes than placebo, abstinence, reduction in frequency of binge episodes per week. They
were also associated with greater reductions in eating related obsessions and compulsions. Three
placebo-controlled RCTs provided evidence about treating BED patients with anticonvulsants,
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specifically Topiramate. Topiramate was associated with abstinence among a greater percentage
of participants and with greater reductions in binge eating, obsessions and compulsions related to
binge-eating and weight. It also produced greater increases in cognitive restraint and reductions
in hunger, disinhibition, and impulsivity.
Methods
The purpose of this project was to determine the prevalence of being at risk for BED in
patients undergoing weight loss management at a non-insurance-based weight loss clinic. The
first step was to look at how the clinic screened patients for BED on intake. Pre-intervention
intake forms, given to all new patients at the clinic, asked patients if they binge eat and if so
when and with what food. Out of the 100 clinic charts, 20 percent were found to be positive for
BED, with 1 in 5 patients stating that they binge eat based on the three questions asked on intake.
This initial pre-intervention data suggested the need to provide more thorough BED screening
and to provide these patients with evidence-based treatment recommendations, support and
referrals.
The project included screening patients at the weight loss clinic for binge eating using the
Binge Eating Disorder Screener-7 (BEDS-7). This is a validated patient-reported screening tool
designed to identify individuals with probable BED for further evaluation or referral to
specialists. This screener was developed based on the DSM-5 diagnostic criteria for binge eating
and is intended for screening use only and should not be used as a diagnostic tool. According to
Herman et al. (2016), the seven BEDS item (BEDS-7) yielded 100 percent sensitivity and 38.7
percent specificity when used on 97 participants in a noninterventional study. Sixteen were
diagnosed with BED (16 percent female; 17 percent male). The study concluded that
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implementation of the screener in clinical practice would promote better understanding of BED
characteristics and help practitioners identify patients who may have BED for further treatment.
The BEDS-7 screener consists of 7 questions (See Appendix H). Each question assesses
the patient’s eating patterns and behaviors over the last 3 months. If a patient answers “YES” to
question 1, the clinician should continue with questions 2 through 7. If the patient answers “NO”
to question 1, there is no need to proceed with the remainder of the screener. If the patient
answered “YES” to question 2 and checked one of the boxes which assessed how often a patient
engaged in a behavior; sometimes, often, always for all questions 3 through 7, follow-up
discussion of the patient’s eating behaviors and his or her feelings about those behaviors should
be considered. Step 3 of the screener included evaluating the patient based upon the complete
DSM-5 diagnostic criteria for BED.
The second phase of the project included treatment recommendations for patients who
screened positive for binge eating. This included self-help, determining patient interest in
pharmacological treatment especially with Topiramate, and referrals to psychotherapy or support
groups. Patients were asked to choose a preference of what might work best for them. Handouts
with a brief description of BED and the three treatment options were given to patients at risk
(See Appendix H). According to Perkins et al., (2009), self-help treatments in BED aim to
improve clinical outcome as well as provide information by teaching patients relevant skills to
overcome and manage this disorder. Self-help treatments have shown efficacy, can be accessed
with minimum delay and are acceptable to many patients. The self-help option consisted of free
online modules and self-help programs for BED with a psychotherapist and an eating disorder
specialist as well as an online training for mindful eating for BED. These were free of charge and
the patient could do them at their own pace. The purpose of the self-help option was to teach
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patients better eating habits, to teach them how to recognize their triggers, and to educate them
on the health impact of BED.
Of the pharmacological options available in treating binge eating disorder, Topiramate
has been found to be useful in BED with obesity, decreasing weight and obsessive-compulsive
eating pathology, as well as eating impulsivity. It has been shown to reduce hunger, promote
weight loss and reduce binge episodes and impulsivity. Topiramate was associated with
abstinence and with greater reductions in binge eating, obsessions and compulsions related to
binge-eating, and weight; it also produced greater increases in cognitive restraint and reductions
in hunger, disinhibition, and impulsivity. (AHRQ, 2015) Pharmacological therapy in BED is
specifically focused on the reduction of eating impulsiveness, binges and negative feelings. Data
were not sufficient to recommend pharmacotherapy as single first-line therapy however,
medications do play an important role in BED management.
The referrals option included both online and in class support groups as well as referrals
to psychotherapists. The class support groups included organizations such as Compulsive Eaters
Anonymous and Overeaters Anonymous which provided face to face or telephone meetings as
well as group meetings. Online support groups were available through social media and other
popular support group platforms. Patients who scored positive on the screener were educated on
BED, the signs and symptoms, risk factors and health implications. Treatment options were
discussed with each patient and they were asked to choose a treatment preference based on what
would ideally work the best for them stressing the importance of compliance.
Results
A total of forty-four patients were screened for binge eating disorder. Thirty patients
screened positive for being at risk for BED with a score of 2-6 on the BEDS-7 Screener. A score
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of 2-3 were considered mildly at risk of BED, a score of 4-5 were determined to be moderately at
risk for BED, and a score of 6 indicated severely at risk for BED. Eight patients were in the mild
category, 10 patients were moderate, and 9 patients were in the severe category. Demographics
for the patients included an average age of 47.2 years old. 89 percent were female, 11 percent
were male, 73 percent were Caucasian, 20 percent were Hispanic, and 7 percent were Asian.
As illustrated in Figure 1, the prevalence of being at risk for BED in this clinic was found
to be 52 percent which surpasses the results of APA at 30 percent of those seeking weight
management. (APA, 2012).

Prevalence of BED
60%
50%
40%
30%
20%
10%
0%

BED

APA

Figure 1: This figure illustrates the prevalence of BED at this clinic as compared to the
results from a study conducted by the American Psychological Association (APA)

The mean body mass index (BMI) at the beginning of the project was 30.7 which falls
into obese category. The BMI was calculated 1 month after the screening intervention had been
implemented and treatment recommendations provided. The mean BMI was found to be 28.3,
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which falls in the overweight category indicating that these patients did lose weight a month after
starting the weight loss program and after being screened for BED. The average weight loss of
the patients who screened positive for being at risk for BED was 2 pounds compared to 2.9
pounds for those patients who scored negative on the screener indicating the possibility that
patients with BED have a slightly harder time losing weight compared to those patients who do
not have BED.
Comorbidities were also compared in those patients with BED and those without BED to
determine if there was an increase in comorbidities associated with BED and if these patients had
a difficult time losing weight. Only a few of the patients at this clinic had major comorbidities,
specifically, the metabolic syndromes of diabetes mellitus, hypertension, hyperlipidemia and
heart disease. Only 6 out of the 44 patients were found to have either diabetes mellitus,
hypertension or hyperlipidemia. There were no patients with heart disease. These patients lost
the same amount of weight as their counterparts. Patients with the above comorbidities did not
score higher or lower on the BEDS-7 screener.
As outlined in Figure 2, the treatment preferences for BED, 63 percent chose the selfhelp option, 32 percent chose medications specifically Topiramate, and 5 percent chose referrals.
The patients who chose the self-help option preferred this mode of treatment due to its ease of
access.
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Figure 2: This figure illustrates the patient treatment preferences for BED

This project concluded that BED is prevalent in those seeking weight loss at this clinic.
Twenty-seven of the total patients screened preferred the self-help option which allowed them
control over their management of this disorder. Fourteen patients were interested in Topiramate
as a treatment option, and only 2 chose referrals to support groups and psychotherapy.
Cost Benefit Analysis
Binge eating disorder is a serious health serious condition that impairs health-related
quality of life (HRQL) and increases health care costs. Evidence shows that patients with BED
have higher health care costs compared to patients who do not. Per year health care cost for
patients with BED is estimated at $33,000 compared to $19,000 in patients without BED (Binge
Eating Disorder Association, 2016). Patients who seek help with BED may reduce their overall
health care costs. Since this was a screening project which included recommendations for
treatment, no cost was charged to the patients for the screening as this was provided cost free by
the clinic. The total cost of printed materials given to patients was $ 50 dollars. The patient
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handout was given to all patients at no charge. The clinic did not incur any costs associated with
screening these patients. Patients seeking weight loss at this clinic pay for their treatments out of
pocket, as it is not an insurance-based clinic. Future considerations include the potential financial
cost of Topiramate, as this project only focused on assessing the interest in Topiramate in those
patients who screened positive for BED.
Discussion
The prevalence of being at risk for BED in this weight loss clinic is 52 percent, which is
significantly higher than other patients seeking weight loss. The prevalence of being at risk for
BED demonstrates the need for increased screening methods in primary care settings. The 7-item
Binge-Eating Disorder Screener (BEDS-7), a brief screener for BED, can assist practitioners in
identifying patients who may have BED and making the necessary follow-up decisions related to
patient referrals or additional assessment and potential diagnosis of BED. Providers can easily
identify those patients at risk for binge eating disorder and provide them with the appropriate and
evidence-based treatments, referrals and follow up. Screening patients for BED helps promote a
better understanding of binge eating habits and raises awareness of its overall impact on health
and quality of life.
Implications for Practice
Binge eating disorder has been linked with several comorbid health conditions, including
diabetes, hypertension, stroke, and heart disease, and other psychiatric illnesses such as anxiety
and depression. It is prevalent in patients seeking weight loss management and is likely to be
prevalent in primary care settings. The condition is significantly under diagnosed despite it being
the most common eating disorder in the United States and is more prevalent than anorexia and

SCREENING FOR BINGE EATING DISORDER IN PATIENTS
bulimia combined. Health care practitioners can be influential in ensuring that patients are
adequately screened and provided with adequate treatment, referrals and follow up.
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